Strongylin A

Strongylin A

SCHEMBL8273902

COc1ccc(O)c2c1C[C@]1(C)[C@@H](C)CCC3C(C)(C)CCC[C@]31O2

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CETP P11597 7/20 1.00
ENTPD5 O75356 3/20 0.53
PTGS2 P35354 1/20 0.42
ALOX15 P16050 2/20 0.36
ALOX12 P18054 2/20 0.36
ST6GAL1 P15907 3/20 0.35
ST3GAL1 Q11201 2/20 0.35
ST3GAL3 Q11203 2/20 0.35
FUT6 P51993 1/20 0.33
FUT5 Q11128 1/20 0.33
PIK3CA P42336 2/20 0.33
PIK3CG P48736 2/20 0.33
HSP90AA1 P07900 1/20 0.32
KDM4E B2RXH2 1/20 0.32
MEN1 O00255 1/20 0.32
USP2 O75604 1/20 0.32
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Strongylin A SCHEMBL31536139 1.00 CETP (1.00) CETPENTPD5PTGS2ALOX15ALOX12
SCHEMBL8148354 0.67 CETP (0.51) CETPENTPD5ST6GAL1ST3GAL1ST3GAL3
SCHEMBL31292860 0.61 CETP (0.47) CETPENTPD5ALOX15ALOX12
(+/-)-Wiedendiol B SCHEMBL8275931 0.60 CETP (1.00) CETPPTGS2ALOX15ALOX12PIK3CA
(+/-)-Wiedendiol B SCHEMBL1229327 0.60 CETP (1.00) CETPPTGS2ALOX15ALOX12PIK3CA
SCHEMBL6658224 0.57 MEN1 (0.44) CETPALOX15ALOX12KDM4EMEN1
SCHEMBL6439147 0.56 ADRA1A (0.49) CETPKDM4EMEN1TP53KMT2A
SCHEMBL12234374 0.56 PIK3CB (0.48) CETPENTPD5PTGS2ALOX15ALOX12
SCHEMBL16984748 0.54 CETP (0.39) CETPENTPD5MEN1CYP3A4KMT2A
SCHEMBL5723031 0.54 PDE4A (0.42) CETPKDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005117869-A1 COMBINATIONS COMPRISING (S)-AMLODIPINE AND A CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITOR, AND METHODS FOR REDUCING HYPERTENSION SEPRACOR INC. (US) 2005-12-15 WO disclosed